Scientific Committee Co-Chairs

Richard Baum
Peter MacCallum Cancer Centre

Professor Richard Baum is Professor of Nuclear Medicine, Chair and Clinical Director at the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (TCMRMI), ENETS Center of Excellence, Zentralklinik Bad Berka, Germany. In 1996 Richard Baum was Professor of Nuclear Medicine at the University of Frankfurt/Main, and from 1997 Chair and Clinical Director TCMRMI Bad Berka. Richard has also published a range of research papers within his field of expertise.

Michael Hofman
Peter MacCallum Cancer Centre

Associate Professor Michael Hofman is a nuclear medicine physician at the Centre for Molecular Imaging, Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia’s only public hospital dedicated to cancer treatment, research and education. He has a vision of improving patient outcomes by using molecular imaging to non-invasively characterise disease thereby enabling improved selection of the most appropriate therapy for an individual patient and better assessment of therapeutic response. He has particular interest in novel F-18 and Ga-68 PET radiotracers, and Theranostic applications including neuroendocrine and prostate tumours. He is principal investigator of the first Australian prospective trial of Lu-177 PSMA in prostate cancer, and separately a multi-centre trial of PSMA PET for staging prostate cancer. He is a fellow of the International Cancer Imaging Society and currently serves as an Associate Editor for several journals including Cancer Imaging, Leukaemia Lymphoma and the Journal of Medical Imaging and Radiation Oncology.